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Edited by Judit OvadiAbstract Two novel 21-residue antimicrobial peptides, areni-
cin-1 and arenicin-2, exhibiting activity against Gram-positive
and Gram-negative bacteria and fungi, were puriﬁed from
coelomocytes of marine polychaeta Arenicola marina (lugworm)
by preparative gel electrophoresis and RP-HPLC. Molecular
masses (2758.3 and 2772.3 Da) and complete amino acid
sequences (RWCVYAYVRVRGVLVRYRRCW and RWCVY-
AYVRIRGVLVRYRRCW)1 were determined for each isoform.
Each arenicin has one disulﬁde bond (Cys3-Cys20). The total
RNA was isolated from the lugworm coelomocytes, RT-PCR
and cloning were performed, and cDNA was sequenced. A 202-
residue preproarenicin contains a putative signal peptide (25
amino acids) and a long prodomain. Arenicins have no structure
similarity to any previously identiﬁed antimicrobial peptides.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Aquatic invertebrate animals have no acquired immunity
with a system of antibodies diversiﬁcation. They are presumed
to use their innate immune system as principal defense against
potential pathogens. Endogenous antimicrobial peptides
(AMPs) are the earliest molecular factors in the evolution of
innate immunity and are considered to play a key role in in-
vertebrate host defense [1,2]. AMPs display broad-spectrum
activity against pathogenic bacteria, fungi, and enveloped vi-
ruses. Many aquatic species, which live in a microbe laden
environment, possess an AMPs-based defense system. A va-
riety of AMPs were discovered and characterized from repre-
sentatives of aquatic invertebrates, including marine sponge,* Corresponding author. Fax: +7-095-336-43-33.
E-mail address: ovch@ibch.ru (T.V. Ovchinnikova).
1 The protein sequence data reported in this paper will appear in the
Swiss-Prot and TrEMBL knowledgebase under the accession numbers
P84105 for arenicin-1 and P84106 for arenicin-2.
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are AMPs from the marine sponge Discodermia kiiensis [3];
from hemocytes and plasma of the mussels Mytilus gallopro-
vincialis and Mytilus edulis [4–6], from skin and mucus of the
sea hare Dolabella auricularia [7]; from hemocytes of the Jap-
anese horseshoe crabs Tachypleus tridentatus [8] and Limulus
polyphemus [9], of the shore crab Carcinus maenas [10,11], of
the blue crab Callinectes sapidus [12], and of the shrimp Li-
topenaeus (Penaeus) vannamei [13]; from the solitary tunicates
Styela clava [14–16], Styela plicata [17], and Halocynthia aur-
antium [18,19]. The described AMPs include the cysteine-
rich peptides of mussels (myticin) [5] and horseshoe crabs
(tachyplesins and polyphemusins) [8], the proline and cystein–
rich peptides from shrimp (penaeidins) [13], the a-helical
peptides from ascidians (clavanins, styelins) [14–16]. Antimi-
crobial peptides from marine organisms could aﬀord design
of new antibiotics manifesting broad-spectrum antibacterial
activity in the presence of physiological or elevated NaCl
concentrations.
We have discovered a new family of small (21-residue) an-
timicrobial peptides, termed arenicins, in coelomocytes of
marine polychaeta lugworm Arenicola marina. These AMPs
exhibited activity against Gram-positive, Gram-negative bac-
teria and fungi. Arenicins have a single disulﬁde bond Cys3–
Cys20, forming a 18-residue ring, and have no sequence
homology to any previously identiﬁed AMPs. The puriﬁcation,
primary structure, antibiotic properties and structure of the
preproarenicins mRNA are described in this report.2. Materials and methods
2.1. Materials
All solutions were prepared using water from a Milli-Q plus 185
apparatus (Millipore). Solvents were of high performance liquid
chromatography (HPLC) grade. All reagents were of analytical grade.
2.2. Preparation of coelomocytes of the marine polychaeta
Arenicola marina
Lugworms A. marina were collected at a coastal zone (the island
Sredniy, White Sea, Russia) in the middle of August when reproduc-
tion season of polychaeta was over. Coelomic ﬂuid was harvested by
puncturing the worm body wall with a sterile syringe and kept at 4 C.
Plasma was separated by centrifugation at 400 g for 10 min.
Coelomocyte pellets were stored in a freezer.ation of European Biochemical Societies.
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Before puriﬁcation procedure the coelomocytes were thawed, re-
suspended in 10% acetic acid (1 g per 10 ml of 10% CH3COOH),
homogenized and stirred overnight at 4 C. Centrifugation (25 000 · g,
2 h, 4 C) was used to clarify the supernatant which was taken for
further puriﬁcation procedure. Supernatant was passed under pressure
through a stirred ultraﬁltration cell (Amicon, Danvers MA) equipped
with a YM-10 ﬁlter. The ultraﬁltrate was dried in vacuo (Speed Vac
Concentratror CS-18, Savant Instruments, Hickville, NY) and applied
to preparative continuous acid–urea PAG electrophoresis [20].
Aliquots of each fraction were tested for antimicrobial activity by ra-
dial agar-diﬀusion assay. Active fractions were puriﬁed by reverse-
phase HPLC on a Vydac C-18 column with a linear gradient of
acetonitrile concentration from 0% to 60% (1%min1) in 0.1% TFA.
The peptides of interest were examined by gel electrophoresis.
2.4. Gel electrophoresis
Tricine–SDS PAGE [21] and acid–urea PAGE [22] were performed
in minigels using a SE 250 vertical gel unit (Hoefer, San Francisco,
CA). Gels were stained with a solution that contained 1 g of Coo-
massie brilliant blue R-250 (Sigma), 270 ml methanol, 630 ml water
and 150 ml formaldehyde, and were then destained in 5% acetic acid.Fig. 1. (A) HPLC puriﬁcation of arenicins; (B) tri2.5. Antimicrobial assay
Antimicrobial activities of the peptides were measured in radial
diﬀusion assays by the gel overlay techniques [23]. Samples were
tested for antimicrobial activity against Escherichia coli strain ML-
35p, Listeria monocytogenes strain EGD and Candida albicans strain
820. The underlay agars used for all organisms had a ﬁnal pH of 6.5
and contained 9 mM sodium phosphate, 1 mM sodium citrate, 1%
w/v agarose and 0.3 mg/ml of trypticase soy broth powder (BBL,
Cockeysville, MD). 10 units of activity in radial diﬀusion assay
correspond to a 1 mm diameter clear zone around the 3 mm sample
well. Puriﬁed arenicin-1 and arenicin-2, and porcine protegrin-1 were
dissolved in 0.01% acetic acid at a concentration of 120 lg/ml, and
six additional 2-fold serial dilutions in 0.01% acetic acid were per-
formed. 5 ll of each solution was tested in thin agarose gels. MIC
were deﬁned in low (10 mM sodium phosphate buﬀer, pH 7.4) and
high (10 mM sodium phosphate buﬀer, 100 mM NaCl) concentra-
tions of salt.
2.6. Molecular mass determination
The molecular masses of the puriﬁed AMPs were determined by
matrix-assisted laser desorption ionization mass spectromentry
(MALDI-MS) with a Vision 2000 mass spectrometer (ThermoBio-cine–SDS PAGE; and (C) acid–urea PAGE.
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matrix in 25% methanol and 0.1% TFA.
2.7. Peptide microsequencing
The N-terminal amino acid sequences were determined using the
Procise cLC 491 Protein Sequencing System (PE Applied Biosystems,
USA). Phenylthiohydantoin derivatives of the amino acids were
identiﬁed by the 120A PTH Analyzer (PE Applied Biosystems, USA).
2.8. Reduction and alkylation reaction
Peptide samples were denaturated in 6M guanidinium chloride, 0.2
M Tris–HCl, pH 8.5, and reduced by incubation with a 10:1 molar
excess of dithiothreitol at 25 C for 4 h under N2 atmosphere, and
alkylated using a 5:1 molar excess of 4-vinylpyridine at 25 C for 3 h
under N2 atmosphere. The S-pyridylethylated peptides were desalted
by reverse-phase HPLC on a Vydac C-4 (4.6 250 mm, 5 lm) column
with a linear gradient of acetonitrile concentration from 0% to 60%
(1%min1) in 0.1% TFA at a ﬂow rate of 0.5 ml/min.
2.9. Total RNA isolation
To preserve RNA before total RNA isolation, the dissected fresh
tissues of the lugworm A. marina were submerged in RNA stabilization
solution RNAlaterTM (Ambion Inc., Austin, TX, USA), which rapidly
penetrates tissues, inactivates nucleases and protects RNA from deg-
radation prior to nucleic acid isolation. Samples were placed in 10
volumes of RNAlater and stored at )20 C. Frozen samples were
thawed, removed from the solution and homogenized in liquid nitro-
gen. Intact total RNA was isolated by using SV Total RNA Isolation
System (Promega Corporation, Madison, WI, USA).
2.10. Reverse transcription-PCR
To determine the structure of the 30 and 50 ends of arenicin cDNA,
the RACE strategy was used. RT-PCR experiments were conducted
with SMARTTM RACE cDNA Ampliﬁcation Kit (BD Biosciences
Clontech, Palo Alto, CA, USA). Two degenerate gene-speciﬁc primers
for 30RACE were designed corresponding to the amino acid sequence
of arenicins -Cys3-Val4-Tyr5-Ala6-Tyr7-Val8-Arg9- determined by N-
terminal automated amino acid sequencing of the pyridylethylated
peptides:
No. 1 50-TGC GTC TAC GC(T,C) TA(T,C) GT(T,C) (A,C)G-30
No. 2 50-TGC GTC TAC GC(T,C) TA(T,C) GT(A,G) (A,C)G-30.
The following thermal cycle proﬁle was used for 30RACE PCR: 95
C for 90 s, 35 cycles of 94 C for 30 s, annealing at 50 C for 40 s, and
elongation at 72 C for 120 s. Ampliﬁcation of 50 cDNA end was
performed with two gene-speciﬁc primers complementary to the 30
untranslated region:
No. 3 50-TCT GAG GGC TGC AGA ATC GTC GGT-30
No. 4 50-GTA GAA AAT GTC ATT GAT CCC ATT TCA-30.
In this case, the thermal cycle proﬁle was slightly modiﬁed by in-
creasing the annealing temperature up to 64 C. Products were sepa-
rated by 1.5% agarose gel electrophoresis, stained with ethidium
bromide and viewed with a UV transilluminator.
2.11. RT-PCR products cloning and sequencing
The main PCR products were eluted from low melting point
agarose gel and cloned in pGEM-T vector (Promega). Basic re-
combinant DNA techniques were exploited as described [24]. E. coli
strain DH-10B (Life Technologies, Gaithersburg, MD) competent
cells were transformed and a miniscale preparation of plasmid DNA
was carried out using the alkaline lysis method. Nucleotide se-
quencing analysis was performed by dideoxy chain termination
technique in double stranded vector using the ﬂuorescence-labeled
dye terminator method and an ABI PRISM 3100-Avant automatic
sequencer (Applied Biosystems, USA).Fig. 2. Antimicrobial activity of arenicins (A) against L. monocytoge-
nes; (B) against E. coli; and (C) against C. albicans.3. Results
3.1. Puriﬁcation of AMPs from coelomocytes of Arenicola
marina
To identify and characterize the AMPs from marine poly-
chaeta A. marina, they were isolated from the coelomocytes of
the lugworm in acidic conditions. The coelomocytes wereseparated by centrifugation, kept in a freezer, then thawed,
resuspended in 10% acetic acid and homogenized. After cen-
trifugation, the obtained supernatant was taken for the further
puriﬁcation procedure by ultraﬁltration via Amicon YM-10
ﬁlter. The ultraﬁltrate was dried in vacuo and applied to
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Aliquots of each fraction were tested for antimicrobial activity
by radial agar-diﬀusion assay. Active fractions were puriﬁed
by reverse-phase HPLC on a Vydac C-18 column with a linear
gradient of acetonitrile concentration (Fig. 1). The peptides of
interest were examined by gel electrophoresis in tricine–SDS
PAGE (Fig. 1A) and acid–urea PAGE (Fig. 1B). RP-HPLC
procedure resulted in puriﬁcation to homogenety of two in-
dividual lugworm peptides. The peptides were named arenicin-
1 and arenicin-2 according to their elution order from the
HPLC column.
3.2. Biological activity of arenicins
Both arenicins were shown to be active against Gram-posi-
tive L. monocytogenes, strain EGD (Fig. 2A), Gram-negative
E. coli, strain ML-35p (Fig. 2B) and fungi C. albicans, strain
820 (Fig. 2C). Antimicrobial activities of both arenicins were
absolutely equal in all tests. At doses exceeding 25 lg/ml, both
arenicins inhibited growth of the microorganisms with eﬀec-
tiveness comparable with that of one of the most strong pep-
tide antibiotics protegrin-1 [25]. Under low salt conditions,
arenicins and protegrin-1 had approximately equal activities
against L. monocytogenes (MIC 0.6 and 0.8 lg/ml, respec-
tively), but arenicins were less potent against E. coli (MIC 4 lg/
ml) and C. albicans (MIC 4.5 lg/ml) than protegrin-1 (MIC 0.7
and 0.8 lg/ml, respectively). The presence of 100 mMNaCl did
not inﬂuence on activity of arenicins against E. coli and of
protegrin-1 against all tested microorganisms. The activity of
arenicins against C. albicans was strongly reduced (MIC 20 lg/
ml). It is interesting to note that the activity of arenic-
ins against L. monocytogenes also increased slightly (MIC
0.4 lg/ml).Fig. 3. Sequence of mRNA encoding preproarenicin-1 and its translation.
components: signal peptide (dark gray), prosequence (light gray); and matur3.3. Molecular characterization of arenicins
MALDI mass analysis of the puriﬁed arenicins revealed two
diﬀerent molecular ion masses at m/z 2758.1 and m/z 2772.3.
Reduction of arenicins with dithiothreitol and alkylation with
vinylpyridine led to mass shifts of 212.2 Da for arenicin-1 and
of 212.4 Da for arenicin-2. These results demonstrate that the
two cysteine residues of each arenicin are engaged in one di-
sulﬁde bridge. A partial 20 residue N-terminal amino acid se-
quence of each S-pyridylethylated (PE) arenicin was obtained
by automatic Edman degradation: Arg1-Trp2-PECys3-Val4-
Tyr5-Ala6-Tyr7-Val8-Arg9-Val/Ile10-Arg11-Gly12-Val13-Leu14-
Val15-Arg16-Tyr17-Arg18-Arg19-PECys20-X21.
In order to obtain the complete arenicins sequences, the
cDNA sequences were determined.
3.4. Total RNA isolation, RT-PCR, cloning and sequencing
The fresh tissues of the lugworm A. marina were submerged
in RNA stabilization solution and then homogenized in liquid
nitrogen. Total RNA was isolated by using spin columns pu-
riﬁcation system. To determine the structure of the 30 and 50
ends of arenicin cDNA, the RACE strategy was used. A set of
30RACE reactions using two degenerate primers speciﬁc for
mature arenicins showed a main band of approximately 600 bp
in both cases. Cloning and sequencing of the fragment ac-
quired with primer No. 1 revealed the C-terminal sequence of
mature arenicin-1 and the 30UTR of its cDNA. The remaining
part of full-length cDNA for arenicin-1 was determined by the
following 50RACE experiments. At this stage, the 50-terminal
part of cDNA coding for arenicin-2 was also obtained. Both
sequences (GenBank Accession Nos.: AY684856, AY684857)
included a 609-bp open reading frame encoding a peptide
precursor of 202 amino acid residues (Fig. 3). The 50UTR andThe open reading frame is represented with the following individual
e peptide (black).
Fig. 4. Diﬀerences between arenicin-1 and arenicin-2 precursors. The mature peptides are shown in black, signal peptides in dark gray; and
substituted amino acids are highlighted.
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of homology (data not shown). Besides Val/Ile interchange
within the mature peptide, 12 other nucleotide substitutions,
leading to six additional amino acid changes in a precursor
molecule, were detected (Fig. 4). Noteworthy, two clusters of
tandem repeats were found within the 30UTR just after the
stop codon. This fact was taken into account when designing
primers for 50RACE. BLAST search of protein and nucleic
acid databases (http://www.ncbi.nlm.nih.gov/BLAST) did not
reveal signiﬁcant similarities with known sequences. The se-
quence analysis using SignalP (http://www.cbs.dtu.dk/services/
SignalP/) pointed out the Cys25–Asp26 bond as the most
probable cleavage site for eukaryotic signal peptidases [26,27].4. Discussion
The present study describes the isolation and characteriza-
tion of two novel 21-residue antimicrobial peptides, arenicin-1
and arenicin-2, which exhibited activity against Gram-positive,
Gram-negative bacteria and fungi. Arenicins were puriﬁed
from coelomocytes of marine polychaeta A. marina. Complete
amino acid sequences (RWCVYAYVRVRGVLVRYRRCW
and RWCVYAYVRIRGVLVRYRRCW) were determined
for each isoform. The calculated molecular masses of the
arenicin-1 (2758.32 Da) and arenicin-2 (2772.35 Da) matched
the measured masses of the isolated peptides (2758.1 and
2772.3 Da).
AMPs containing a single disulﬁde bond earlier were iso-
lated from frog skin (brevenins [28], pipinins [29], esculentins
[30], ranalexins [31], ranatuerins [32], gaegurins [33], rugosins
[34], palustrins [35], nigrocins [36], and japonicins [37]). All
these peptides are characterized by a single intramolecular
disulﬁde bridge between two cysteine residues forming a small
6–8-residue ring at the C-terminal part of the molecule. A 21-
residue peptide thanatin, containing a single disulﬁde bridge,
forming an octapeptide ring, was isolated from the hemipteran
insect Podisus maculiventris [38]. Cationic antimicrobial do-
decapeptide with one disulﬁde bond, forming a nonapeptide
ring, was puriﬁed from bovine neutrophils [39]. Four broad-
spectrum, 11 and 12 residue antimicrobial peptides, isolated
from skin secretions of the Indian frog Rana tigerina andnamed tigerinins, are characterized by a single intramolecular
disulﬁde bridge, forming a nonapeptide ring [40]. Database
searches did not show sequence similarities of arenicins with
any known AMP. Both arenicins have a single disulﬁde bridge
(Cys3–Cys20), forming a large 18-residue ring. In the light of
these results, we can consider arenicins as the ﬁrst example of a
new class of antimicrobial peptides.
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